Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.
|Grade||Last Price||% Change||$ Change|
ACHN closed up 0.95 percent on Thursday, February 23, 2017, on 78 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Trend Table & Recent Alerts
|Weak or Absent||Down||Flat||Down|
|See historical ACHN trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 23||Crossed Above 50 DMA||Bullish||0.00%|
|Feb 23||Calm After Storm||Range Contraction||0.00%|
|Feb 22||Fell Below 50 DMA||Bearish||0.95%|
|Feb 21||Calm After Storm||Range Contraction||-2.53%|
|Feb 17||50 DMA Support||Bullish||-0.70%|
|Feb 17||Doji - Bullish?||Reversal||-0.70%|
|Feb 17||Calm After Storm||Range Contraction||-0.70%|
|Feb 16||50 DMA Support||Bullish||-0.70%|
|Feb 16||Wide Range Bar||Range Expansion||-0.70%|
|Feb 16||Bearish Engulfing||Bearish||-0.70%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The companys drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Is ACHN a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ACHN news...
|52 Week High||10.06|
|52 Week Low||3.78|
|200-Day Moving Average||6.77|
|50-Day Moving Average||4.22|
|20-Day Moving Average||4.27|
|10-Day Moving Average||4.34|
|Average True Range||0.2|
|Chandelier Exit (Long, 3 ATRs)||4.14|
|Chandelier Exit (Short, 3 ATRs)||4.53|
|Upper Bollinger Band||4.58|
|Lower Bollinger Band||3.96|
|Percent B (%b)||0.45|